Turkish oncologists evaluate chemotherapy for elderly patients by measuring physiological reserve rather than chronological age. Specialists prioritize the ECOG Performance Status to assess daily activity levels. They also integrate the G8 screening tool to identify frailty and predict treatment tolerance accurately.
- Functional assessment: Doctors use ECOG scales to measure a patient ability to perform daily tasks.
- Screening tools: Specialists apply the G8 and VES-13 tests to predict chemotherapy toxicity levels.
- Comorbidity review: Teams evaluate heart and kidney health to prevent dangerous drug-drug interactions.
- Support systems: Physicians verify family caregiver availability to assist with complex side effect management.
Bookimed Expert Insight: Data shows Turkish oncologists often hold international board certifications and prioritize sub-specialized oncology. For instance, Dr. Mutlu Demiray at Medical Park Group focuses on metabolically supported treatments. This approach helps tailor chemotherapy doses for elderly patients with complex nutritional needs.
Patient Consensus: Patients note that Turkish doctors involve the whole family in every treatment stage. They feel much safer when doctors explain how to manage medications at home. Many say the personal attention from nursing staff helped them tolerate the therapy cycles.
